Article
Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience.
Blood transfusion = Trasfusione del sangue - 1 May 2022
Parchure Disha, Madkaikar Manisha, Kulkarni Swati
Abstract excerpt
BACKGROUND: The discovery of the cell-free foetal DNA (cffDNA) circulating in the maternal plasma enabled prediction of foetal RHD thus eliminating the risks associated with invasive procedures. Non-invasive foetal RHD genotyping has now become the standard approach in developed countries for management of alloimmunised women and is also used for targeted antenatal prophylaxis in non-alloimmunised women....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
